Withuspharmaceutical Ownership

330350 Stock  KRW 6,700  50.00  0.74%   
The market capitalization of Withuspharmaceutical is W122.03 Billion. Withuspharmaceutical owns significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the company is less than the current market value, you may not be able generate positive returns on investment in the long run.
Some institutional investors establish a significant position in stocks such as Withuspharmaceutical in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Withuspharmaceutical, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Withuspharmaceutical CoLtd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Withuspharmaceutical Stock Ownership Analysis

About 56.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Withuspharmaceutical had 3:2 split on the 11th of June 2021. Withus Pharmaceutical Co., Ltd. produces and sells pharmaceutical products in South Korea. The company was founded in 2005 and is headquartered in Seoul, South Korea. Withus Pharm is traded on Korean Securities Dealers Automated Quotations in South Korea. For more info on Withuspharmaceutical CoLtd please contact the company at 82 2 3486 7474 or go to http://www.withuspharm.com.

Pair Trading with Withuspharmaceutical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Withuspharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Withuspharmaceutical will appreciate offsetting losses from the drop in the long position's value.

Moving together with Withuspharmaceutical Stock

  0.94102940 Kolon Life SciencePairCorr
  0.84074430 Aminologics CoLtdPairCorr
  0.77023910 Daihan PharmaceuticalPairCorr
The ability to find closely correlated positions to Withuspharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Withuspharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Withuspharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Withuspharmaceutical CoLtd to buy it.
The correlation of Withuspharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Withuspharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Withuspharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Withuspharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Withuspharmaceutical Stock

Withuspharmaceutical financial ratios help investors to determine whether Withuspharmaceutical Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Withuspharmaceutical with respect to the benefits of owning Withuspharmaceutical security.